This vial contains two peptides that act on the growth hormone axis through different receptors. CJC 1295 is a GHRH analog engaging the GHRH receptor; Ipamorelin is a selective agonist at the ghrelin receptor, GHS-R1a.
Combining them is a standard approach in preclinical work examining growth hormone secretion pulsatility, since the two receptor pathways converge on the same somatotroph population. The pre-blended format removes a compounding step. Both components are assayed separately.
Supplied as a sealed vial for laboratory use. This material is offered strictly for in vitro research and is not for human or veterinary consumption, diagnostic, or therapeutic use.
Reviews
There are no reviews yet.